Aclaris Therapeutics, Inc.
Nasdaq · Healthcare · Pharmaceutical Preparations · Wayne, PA
ACRS chart
What traders are saying about $ACRS
Latest postsAclaris Therapeutics, Inc. news
- Aclaris Therapeutics, Inc. (ACRS) Stock Price, News, Quote & History
Yahoo! Finance Canada ·
- Aclaris Therapeutics Stock Price Forecast. Should You Buy ACRS?
StockInvest.us ·
- CCORF Maintains Aclaris Therapeutics(ACRS.US) With Buy Rating, Maintains Target Price $13
Moomoo ·
- Is Acadia Healthcare (ACHC) Stock Outpacing Its Medical Peers This Year?
Yahoo Finance ·
- Aclaris Therapeutics Raises $50M in Wayne, PA Stock Offering
Hoodline ·
- Operating cash use rises to $62.1M at Aclaris Therapeutics (ACRS) as its nine-month loss widens.
Stock Titan ·
- Aclaris Therapeutics, Inc. reports results for the quarter ended September 30 - Earnings Summary
TradingView ·
- Aclaris Therapeutics Q3 Results: Loss narrows to $0.12 per share
scanx.trade ·
- Aclaris Therapeutics Inc earnings beat by $0.04, revenue topped estimates
Investing.com ·
- Aclaris Therapeutics (ACRS) Reports Q3 Loss, Beats Revenue Estimates
Yahoo Finance ·
- Form 8K Aclaris Therapeutics Inc For: 5 November By Investing.com
Investing.com UK ·
- Aclaris: Q3 Earnings Snapshot
Yahoo Finance ·
Aclaris Therapeutics, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $7.8M | $18.7M | $31.2M | $29.8M |
| Net income | -$64.9M | -$132.1M | -$88.5M | -$86.9M |
| Diluted EPS | $-0.53 | $-1.71 | $-1.27 | $-1.33 |
| Total assets (year end) | $160.5M | $220.3M | $197.4M | $254.6M |
| Cash and equivalents (year end) | $20.0M | $24.6M | $39.9M | $45.3M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Aclaris Therapeutics, Inc.
- Ticker
- ACRS (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- Wayne, PA
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1557746
Frequently asked questions
What exchange is Aclaris Therapeutics, Inc. listed on?
Aclaris Therapeutics, Inc. trades on the Nasdaq under the ticker symbol ACRS.
What industry is Aclaris Therapeutics, Inc. in?
Aclaris Therapeutics, Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Aclaris Therapeutics, Inc. headquartered?
Aclaris Therapeutics, Inc.'s business address on file with the SEC is in Wayne, PA.
When does Aclaris Therapeutics, Inc.'s fiscal year end?
Aclaris Therapeutics, Inc.'s fiscal year ends on December 31.
How much revenue did Aclaris Therapeutics, Inc. report?
Aclaris Therapeutics, Inc. reported $7.8M in revenue for calendar year 2025, according to its SEC filings.